Hospira Inc Issues A Voluntary Nationwide Recall For Buprenorphine Hydrochloride Injection CarpujectTM Units and Labetalol Hydrochloride Injection, USP CarpujectTM Units Due to the Potential for Incomplete Crimp Seals fda.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fda.gov Daily Mail and Mail on Sunday newspapers.
FOR IMMEDIATE RELEASE - May 21, 2024 - NEW YORK, NY., Hospira, Inc., a Pfizer company , is voluntarily recalling the lots listed in the table below of Buprenorphine Hydrochloride Injection CarpujectTM.
Caplin Steriles gets USFDA approval for Labetalol Hydrochloride Injection USP equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.